Qnovia Initiates First Phase of RespiRx™ Nicotine Inhaler Trial

Jan.13
Qnovia Initiates First Phase of RespiRx™ Nicotine Inhaler Trial
Qnovia, Inc. announces the first patient dosed in the US clinical trial of RespiRx™ Nicotine Inhaler for smoking cessation.

According to PR Newswire's report on January 7th, the US pharmaceutical company Qnovia, Inc. announced that the first patient in the US has been administered with RespiRx™ nicotine inhaler (QN-01) in the phase I clinical trial as a smoking cessation therapy.


RespiRx™ is a drug delivery device that combines a portable handheld nebulizer with a metered dose medication cartridge to administer medication in aerosol form.


Qnovia's CEO Brian Quigley stated,


We are pleased to have administered medication to the first patient in our first clinical trial, aimed at addressing global cigarette use issues and innovating smoking cessation treatment. Overall, we believe today's news represents Qnovia's official transformation into a biopharmaceutical company, developing the next generation of smoking cessation therapies.


This clinical trial aims to address the need for effective and easily accessible smoking cessation therapy, evaluating the pharmacokinetics, safety, and tolerability of RespiRx™. The trial is a randomized crossover open-label study, including up to 24 healthy adult smokers. The primary endpoints are the maximum concentration, AUC 0-30, and Tmax of plasma nicotine after baseline adjustment. The study is being conducted by Vince Clinical Research Company in Overland Park.


The company expects to release the first phase trial data of the RespiRx™ nicotine inhaler in the second quarter of 2025, and submit a clinical trial application in the UK in the second half of 2025.


Qnovia, Inc. is a US-based platform medical technology and pharmaceutical company founded by Mario Danek in 2018. It focuses on developing and commercializing proprietary inhalation device technology to improve patient outcomes. Its flagship product, RespiRx™, is a medication-grade inhalation drug delivery system based on a cartridge, designed to help smokers quit smoking.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Denssi's Global Strategy: Swedish Nicotine Pouch Brand Focuses on Flavor Innovation, Brand Storytelling in Africa and Middle East
Denssi's Global Strategy: Swedish Nicotine Pouch Brand Focuses on Flavor Innovation, Brand Storytelling in Africa and Middle East
Denssi COO Callum Cherry highlights that the brand stands out globally with “great flavors” and a unique story. Using differentiated strategies and sports sponsorships, Denssi builds a youthful, passionate image, focusing on emerging markets in Africa and the Middle East.
Jun.19 by 2FIRSTS.ai
Brazilian Man Sentenced for Illegal E-Cigarette Sales; Products Largely Sourced from China and Paraguay
Brazilian Man Sentenced for Illegal E-Cigarette Sales; Products Largely Sourced from China and Paraguay
A Brazilian man has been sentenced to four years in prison for e-cigarette smuggling and illegal possession of ammunition. The case highlights the use of social media to sell e-cigarettes unlawfully and underscores authorities’ resolve to crack down on the black market.
Jul.22 by 2FIRSTS.ai
New Zealand Ruling Party Accused of Favoring Tobacco Industry; Smoke-Free Groups Urge Prime Minister to Intervene in Tobacco Oversight
New Zealand Ruling Party Accused of Favoring Tobacco Industry; Smoke-Free Groups Urge Prime Minister to Intervene in Tobacco Oversight
New Zealand Vape-Free Kids urges removing New Zealand First’s control over tobacco and vaping regulations. RNZ documents reveal Philip Morris’s close ties with the party, including a legislative draft for heated tobacco products (HTPs) and an excise tax cut on HTPs by MP Casey Costello, benefiting Philip Morris. Party leader Winston Peters says contacts with the tobacco industry are legal.
Jul.23 by 2FIRSTS.ai
Indonesian Tobacco Tycoons Hartono Brothers Become Richest in Indonesia with $50.3 Billion Fortune
Indonesian Tobacco Tycoons Hartono Brothers Become Richest in Indonesia with $50.3 Billion Fortune
The Indonesian tobacco industry has produced top billionaires, with the Hartono brothers holding the top spot with a $50.3 billion fortune. Their family business, Djarum, is not only the largest kretek cigarette supplier but has also expanded its business empire through investments in banking, real estate, and other sectors.
Jun.24 by 2FIRSTS.ai
UK Recycling Plant Fire Linked to E-Cigarette Lithium Battery; Authorities Urge Proper Disposal
UK Recycling Plant Fire Linked to E-Cigarette Lithium Battery; Authorities Urge Proper Disposal
A fire at Biffa’s materials recycling facility in Westgate on July 1 was likely sparked by a lithium battery from an e-cigarette discarded in a blue recycling bag. The blaze was quickly contained. The site had also seen a fire in January that required 60 firefighters. South Staffordshire Council and Biffa are urging the public not to dispose of e-cigarettes, batteries, or similar items in regular waste or recycling bins, but to use designated disposal points instead.
Jul.09 by 2FIRSTS.ai
Malaysian Prime Minister Announces Plan to Impose Health Tax on Vapes and Related Products
Malaysian Prime Minister Announces Plan to Impose Health Tax on Vapes and Related Products
Malaysian Prime Minister Anwar Ibrahim announced in the Lower House that the health promotion tax, previously limited to sugary drinks, will be expanded to include tobacco, vapes, and alcohol. The Health Ministry expects to generate around $9.4 billion in revenue.
Aug.01 by 2FIRSTS.ai